Guggenheim Capital’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $707K | Sell |
55,117
-144
| -0.3% | -$1.83K | 0.01% | 1100 |
|
|
2025
Q4 | $497K | Buy |
55,261
+12,160
| +28% | +$167K | ﹤0.01% | 1281 |
|
|
2025
Q3 | $744K | Sell |
43,101
-6,820
| -14% | -$84K | 0.01% | 1028 |
|
|
2025
Q2 | $468K | Sell |
49,921
-5,668
| -10% | -$46.5K | ﹤0.01% | 1219 |
|
|
2025
Q1 | $395K | Sell |
55,589
-4,000
| -7% | -$40.4K | ﹤0.01% | 1314 |
|
|
2024
Q4 | $695K | Sell |
59,589
-7,358
| -11% | -$115K | 0.01% | 1109 |
|
|
2024
Q3 | $1.38M | Buy |
66,947
+5,681
| +9% | +$131K | 0.01% | 964 |
|
|
2024
Q2 | $1.37M | Sell |
61,266
-2,229
| -4% | -$53.1K | 0.01% | 961 |
|
|
2024
Q1 | $1.75M | Buy |
63,495
+2,301
| +4% | +$63.9K | 0.01% | 936 |
|
|
2023
Q4 | $1.87M | Sell |
61,194
-10,486
| -15% | -$301K | 0.01% | 872 |
|
|
2023
Q3 | $2.27M | Sell |
71,680
-14,962
| -17% | -$580K | 0.02% | 767 |
|
|
2023
Q2 | $3.53M | Buy |
86,642
+3,874
| +5% | +$157K | 0.03% | 648 |
|
|
2023
Q1 | $3.08M | Sell |
82,768
-3,867
| -4% | -$152K | 0.03% | 698 |
|
|
2022
Q4 | $3.02M | Buy |
86,635
+14,977
| +21% | +$712K | 0.03% | 708 |
|
|
2022
Q3 | $4.01M | Sell |
71,658
-7,981
| -10% | -$495K | 0.04% | 586 |
|
|
2022
Q2 | $4.12M | Buy |
79,639
+3,320
| +4% | +$169K | 0.03% | 625 |
|
|
2022
Q1 | $5.55M | Buy |
76,319
+4,877
| +7% | +$413K | 0.03% | 612 |
|
|
2021
Q4 | $8.45M | Buy |
71,442
+14,563
| +26% | +$1.82M | 0.04% | 494 |
|
|
2021
Q3 | $7.63M | Buy |
56,879
+26,388
| +87% | +$4M | 0.05% | 488 |
|
|
2021
Q2 | $4.94M | Sell |
30,491
-617
| -2% | -$48K | 0.03% | 686 |
|
|
2021
Q1 | $2.5M | Buy |
+31,108
| New | +$2.09M | 0.02% | 919 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
